GENE ONLINE|News &
Opinion
Blog

2022-05-27| Special

Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology

by Sahana Shankar
Share To
photo credit to ASCGT

At the 25th annual meeting of the American Society for Cell and Gene Therapy, medical researchers from Japan showcased their expertise in developing gene therapy in a session titled ‘Cutting edge cell and gene therapy research in Japan’. Looking beyond oncology and genetic diseases, Japan’s biomedical community is working on developing new therapies, improving gene therapy efficiency and targeting specific tissues. The session showcased examples of the latest  developments in cell and gene therapy research in Japan. 

 

A roadmap to gene therapy for cardiovascular diseases

 

Dr. Yoshikazu Yonemitsu from Kyushu University reviewed the evolution of RNA therapy for cardiaovascular diseases and the importance of large scale, double-blinded and randomized clinical trials to eliminate biases and errors for evaluating the efficacy of cell therapy. While most gene therapy candidates focus on oncology and genetic diseases, clinical success for cardiovascular diseases has been limited.  

It's free! Log in now to read

LATEST
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
Pharmacogenomics (PGx) Shaping the Dynamic APAC Regions
2024-04-10
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
EVENT
Scroll to Top